CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC

ASCO 2021: Lung roundup

FGFR as a tumour agnostic indicator and its importance in the diagnosis and treatment of multiple solid tumour types

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed MM

Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma

Latest updates in exon 20 insertions focusing on targeted therapies, novel approaches, and implications for patients

Advances in lung cancer and current situation in Romania

Breast cancer roundup from ASCO 2021

EHA 2021: Latest in immunotherapy for R/R multiple myeloma

ALCSI: Raising lung cancer screening awareness in the US

OncoAlert and ecancer ASCO roundup - Day 4 and 5

A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control cohort in R/R FL